IHT SA PTCA Balloon Dilatation Catheter — Swiss Precision in Interventional Cardiology A high-performance RX (Rapid Exchange) balloon catheter manufactured by IHT SA (Switzerland), a specialist in interventional cardiology devices. Designed for the precise dilation of stenosed or blocked coronary arteries during percutaneous coronary intervention (PCI) procedures. Key Benefits: Rapid Exchange (RX) System: Ensures streamlined operation and ease of use for the interventionist during complex procedures. Swiss Engineering: Delivers superior trackability and crossability, even through tortuous and highly stenosed anatomical structures. Precision Performance: A low entry profile combined with controlled compliance allows for efficient lesion preparation prior to stenting. Safety & Reliability: Consistent Rated Burst Pressure (RBP) values ensure a high safety margin during arterial dilation.
IHT Central Asia LLP is a Kazakh-Spanish joint venture and the only manufacturer of coronary stents and balloon catheters in Central Asia, established in 2023. The company produces high-tech interventional cardiology devices based on European technology transfer. Production is localized in Astana and focused on treating ischemic heart disease and preventing myocardial infarction. Product range: Drug-eluting coronary stents (DEStiny) Balloon catheters for angioplasty (Evolve) Solutions for percutaneous coronary interventions Key advantages: Unique regional manufacturer Proven European technology and clinical validation Coverage of Kazakhstan demand (up to 36,000 stents/year) Up to 30% lower cost than imports Export to Central Asia and other markets IHT Central Asia delivers advanced cardiovascular solutions focused on technology, accessibility, and reliability for healthcare systems.
